Canaccord Genuity Maintains a 'Buy' on Immunogen (IMGN); 2012 A Pivotal Year
Tweet Send to a Friend
Canaccord Genuity maintains a 'Buy' on Immunogen Inc. (NASDAQ: IMGN) price target of $14.00.
Canaccord analyst says, "We see 2012 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "We see 2012 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
